Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › FGF21 conjugates and anti-diabetic uses thereof

FGF21 conjugates and anti-diabetic uses thereof

US Patent 8722622 · Granted May 13, 2014

Estimated economic value: $332,864,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Tumor necrosis factor-like ligand 1A specific antibodies and compositions and us2025
Use of marizomib for the treatment of central nervous system (CNS) cancers2024
Tumor necrosis factor-like ligand 1A specific antibodies and compositions and us2022
Dual PDGF/VEGF antagonists2021
Detectors of serum biomarkers for predicting ovarian cancer recurrence2020
Engineered monomeric antibody fragments2019
Dual PDGF/VEGF antagonists2017
Detectors of serum biomarkers for predicting ovarian cancer recurrence2017
Tumor necrosis factor-like ligand 1A specific antibodies and compositions and us2017
Anti-CTLA-4 antibody compositions2016
Anti-diabetic compounds2015
Anti-diabetic compounds2015